| 英文摘要 |
In developed countries, endometrial cancer is the most prevalent gynecological cancer, and obesity is a major modifiable risk factor. Obesity and other clinical variables have a complicated connection with mortality in endometrial cancer survivors, which is probably impacted by molecular alterations unique to the disease. The available data points to potential biochemical pathways mediating these correlations, although the specific processes are not well known. This research aims to clarify the relationships between molecular biology and survival outcomes in patients with endometrial cancer by combining biological changes with epidemiological data. A more thorough comprehension of these correlations may result in more individualized risk assessment and focused treatment plans, which would ultimately enhance patient outcomes. |